Excellent news. That milestone payment is handy
Printable View
I have started to top up at $3.31 ahead of the half year result announcement on 23 November.
This company is obviously making incremental progress in what can be a complex regulatory environment for pharmacuetical products. I am even moved to wonder if they will declare an interim dividend this time notwithstanding they have been somewhat parsimonious towards holders in the past.
Expected boost to share price after announcing that FDA approval hasn’t happened
Went to 350 that day ….but now 326 ……lowest for some time
Suppose holders need to be extremely patient with this one
https://www.nzx.com/announcements/421994
Having this excellent product approved for the China market is a significant achievement.